德国实施2型糖尿病和牙周炎综合护理:基于实践和集群随机试验的研究方案
Patrick Hennrich1, Annika Queder2, Attila Altiner2
1Heidelberg Institute of Global Health Section for Oral Health, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. patrick.hennrich@med.uni-heidelberg.de.
BMC oral health
|August 2, 2024
概括
这项研究引入了一种综合护理途径,用于管理2型糖尿病 (T2DM) 和牙周炎,旨在早期检测和改善患者的治疗结果. 新方法同步牙科和初级保健,以改善健康管理和降低成本.
科学领域:
- 公共卫生 公共卫生
- 综合医疗保健模式的整合
- 慢性疾病管理 慢性疾病管理
背景情况:
- 2型糖尿病 (T2DM) 和牙周炎具有共同的风险因素,并且是双向相关的.
- 当前的医疗保健系统往往将初级保健和口腔健康分开,导致两种病症患者的管理不协调.
- 需要综合护理策略来应对T2DM和牙周炎的同时发生.
研究的目的:
- 评估T2DM和牙周炎患者的新型综合护理途径的实施和有效性.
- 评估T2DM风险查在牙科环境和牙周炎风险查在初级保健中的整合.
- 检查牙医和初级保健医生之间的相互转诊在综合途径中的影响.
主要方法:
- 一种基于实践的多中心方法,涉及两项并行研究:牙科机构的集群随机对照试验和初级保健机构的非随机对照试验.
- 招募166名牙医和248名全科医生,共招募3808名患者.
- 在基线,12个月和24个月收集数据,并进行影响,过程和经济评估,包括对提供商支付偏好的离散选择实验.
主要成果:
- 综合护理途径旨在促进T2DM和牙周炎风险的早期检测.
- 预计这项干预措施将为受影响患者提供及时诊断和治疗干预措施.
- 对管理不同护理环境中复杂,交叉的健康状况的方法学见解.
结论:
- 成功实施可以通过早期检测和治疗T2DM和牙周炎来提高患者的生活质量.
- 综合方法有可能减少整体医疗保健支出.
- 这项研究为跨学科的医疗保健干预提供了新的见解,将通用和牙科实践联系起来.
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:15Diabetes: Management and Pharmacotherapy
247
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
247
01:22Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
01:29Chronic Pancreatitis II: Collaborative Care
79
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
79
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
185
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
185
01:15Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521